生物技术进展 ›› 2018, Vol. 8 ›› Issue (1): 28-33.DOI: 10.19586/j.2095-2341.2017.0042

• 进展评述 • 上一篇    下一篇

抗体药物糖化检测方法及其生物学功能研究进展

张斌1,刘晓志1,周敬华2,魏敬双1,高健1,王志明1*   

  1. 1.华北制药集团新药研究开发有限责任公司, 抗体药物研制国家重点实验室, 石家庄 050015; 2.河北省计划生育科学研究院男科实验室, 石家庄 050000
  • 收稿日期:2017-05-23 出版日期:2018-01-25 发布日期:2017-07-21
  • 通讯作者: 王志明,高级工程师,研究方向为抗体药物研发。E-mail:wzm3994@163.com
  • 作者简介:张斌,工程师,研究方向为抗体药物研发。E-mail:zbc75665@126.com。
  • 基金资助:
    国家重大新药创制项目(2014ZX09201041-004)资助。

Progress on Detection Methods and Biological Functions of Glycation Antibody Drug

ZHANG Bin, LIU Xiaozhi, ZHOU Jinghua, WEI Jingshuang, GAO Jian, WANG Zhiming   

  1. 1.State Key Laboratory of Antibody Research & Development, New Drug Research and Development Company Ltd., North China Pharmaceutical Corporation, Shijiazhuang 050015, China; 2.Hebei Province Family Planning Research Institute Male Laboratory, Shijiazhuang 050000, China
  • Received:2017-05-23 Online:2018-01-25 Published:2017-07-21

摘要: 糖化是一个重要的蛋白质修饰过程,可能影响治疗性蛋白药物(如单克隆抗体药物)的生物活性及分子稳定性。许多研究表明糖化血红蛋白水平升高与心血管疾病及动脉粥样硬化有着密切关系。人体的血浆蛋白,如白蛋白、球蛋白、纤维蛋白和胶原蛋白也可能被糖化,进而形成AGEs,蛋白药物的生产、储存以及药物在体内循环过程中都可能发生糖化反应。综述了治疗性抗体药物糖化的原因、分析方法,以及糖化对抗体药物生物学功能的影响,以期为临床抗体药物的开发、优化及贮存条件研究提供参考。

关键词: 抗体, 糖基化, 分析方法, 生物学功能, 晚期糖基化终末产物

Abstract: Glycation is an important protein modification that could potentially affect bioactivity and molecular stability of the rapeutic proteins such as monoclonal antibodies. Many studies suggested that elevated levels of glycated hemoglobin were closely related with cardiovascular disease and atherosclerosis. Human plasma proteins, such as albumin, globulin, fibrinogen and collagen may be glycosylated, and then forms AGEs. In this paper, we reviewed the root cause and the current analytical methods of glycation of the rapeutic antibodies. We also summarized the effect of glycation on biological function, which was expected to provided reference for research on development, optimizion and storage condition of the rapeutic antibodies.

Key words: antibody, glycation, analytical methods, bioactivity, advanced glycation end products